Inogen gains after FDA approves airway clearing device

** Shares of medical device maker Inogen INGN rise 10.6% to $9.49 premarket

** Co says its device for clearing mucus from lungs has received FDA 510(k) approval

** FDA 510(k) approval is a process where a medical device is shown to be safe and similar to an existing device before it can be sold

** The device, SIMEOX 200 Airway Clearance Device, helps improve bronchial drainage in patients with chronic respiratory diseases - INGN

** The device is intended for patients who can cough on their own - INGN

** Co plans a limited launch of the device at targeted sites in 2025

** As of last close, stock has risen 56.3% YTD